Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today
drug costs
Fierce Healthcare
Revised 340B Rebate Model Pilot Program moves forward
Despite provider pushback, a notice from HRSA sets the mulligan program into motion, targeting a Jan. 1 start and 25 potentially eligible products.
Dave Muoio
Jul 31, 2026 1:15pm
Trump floats countdown to 200% tariff rate on imported generics
Jul 22, 2026 11:00am
Germany approves controversial healthcare reform package
Jul 13, 2026 10:40am
How biosimilar developers are embracing next phase of US market
Jul 6, 2026 10:03am
Colorado wins FDA approval to import cheaper drugs from Canada
Jun 17, 2026 10:30am
Brand-name drug prices climb with age in US, fall abroad: report
May 29, 2026 8:10am